J Plank, A Siebenhofer, A Berghold, K Jeitler, K … - Archives of Internal …, 2005 - Am Med Assoc Results Forty-two randomized controlled trials that assessed the effect of SAI analogues vs regular
insulin in 7933 patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and gestational
diabetes mellitus were identified. The weighted mean difference between hemoglobin A ... Cited by 80 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org J Plank, A Wutte, G Brunner, A Siebenhofer, B … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—With respect to blood glucose excursions from time 0 to 6 h (Exc glu(0–6 h) ) and
from time 0 to 4 h (Exc glu(0–4 h) ), the pharmacodynamic effect of insulin aspart and insulin
lispro can be declared equivalent. This was supported by comparison with maximum ... Cited by 76 - Related articles - BL Direct - All 6 versions
SK McMahon, FL Airey, DA Marangou, KJ … - Diabetic …, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 64 - Related articles - BL Direct - All 5 versions
JL Colquitt, C Green, MK Sidhu, D Hartwell, N Waugh - 2004 - nice.org.uk Page 1. Clinical and cost-effectiveness of CSII for diabetes - CONFIDENTAL CLINICAL
AND COST EFFECTIVENESS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
FOR DIABETES Report commissioned by: NHS HTA Programme ... Cited by 60 - Related articles - View as HTML - All 10 versions
J Colquitt, P Royle, N Waugh - Diabetic Medicine, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 61 - Related articles - BL Direct - All 4 versions
RP Radermecker, AJ Scheen - Diabetes/Metabolism Reviews - interscience.wiley.com Portable insulin infusion devices are effective and safe insulin delivery systems for managing
diabetes mellitus, especially type 1 diabetes. Rapidly absorbed insulin analogues, such as insulin
lispro or insulin aspart, may offer an advantage over regular human insulin for insulin ... Cited by 50 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org IB Hirsch, BW Bode, S Garg, WS Lane, A Sussman, … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Mean serum fructosamine levels were significantly lower after CSII therapy than
after MDI therapy (343 ± 47 vs. 355 ± 50 μmol/l, respectively; P = 0.0001). Continuous glucose
monitoring profiles over a 24-h time period showed that glucose exposure was 24 and ... Cited by 45 - Related articles - All 7 versions
M Vazquez-Carrera, JS Silvestre - Methods Find Exp Clin Pharmacol, 2004 - journals.prous.com Insulin therapy has been strongly influenced by the results of the Diabetes Control and Complications
Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS), both of which support
intensive antidiabetic therapy. Conventional insulin therapy can be limited, due to the ... Cited by 41 - Related articles - All 4 versions
A Siebenhofer, J Plank, A Berghold, K Horvath, PT … - Diabetologia, 2004 - Springer Aims/hypothesis. This study aimed to compare the ef- fect of treatment with short-acting insulin
(SAI) ana- logues versus structurally unchanged short-acting in- sulin (regular insulin) on glycaemic
control and on the risk of hypoglycaemic episodes in type 1 diabetic pa- tients using ... Cited by 39 - Related articles - All 4 versions
